NDC 0378-3097

everolimus

Everolimus

everolimus is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Everolimus.

Product ID0378-3097_04a88f3c-1c88-4940-b577-da0b12d213a2
NDC0378-3097
Product TypeHuman Prescription Drug
Proprietary Nameeverolimus
Generic NameEverolimus
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-09-10
Marketing CategoryANDA / ANDA
Application NumberANDA212936
Labeler NameMylan Pharmaceuticals Inc.
Substance NameEVEROLIMUS
Active Ingredient Strength5 mg/1
Pharm ClassesCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0378-3097-85

4 BLISTER PACK in 1 CARTON (0378-3097-85) > 7 TABLET in 1 BLISTER PACK (0378-3097-32)
Marketing Start Date2020-09-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "everolimus" or generic name "Everolimus"

NDCBrand NameGeneric Name
0054-0470EverolimusEverolimus
0054-0471EverolimusEverolimus
0054-0472EverolimusEverolimus
0054-0480EverolimusEverolimus
0054-0481EverolimusEverolimus
0054-0482EverolimusEverolimus
0054-0497EverolimusEverolimus
0054-0604EverolimusEverolimus
49884-119EverolimusEverolimus
49884-127EverolimusEverolimus
49884-125EverolimusEverolimus
0378-3098everolimuseverolimus
0093-7766EverolimusEverolimus
0378-3097everolimuseverolimus
0093-7767EverolimusEverolimus
0093-7768EverolimusEverolimus
0378-3096everolimuseverolimus
0078-0414Zortresseverolimus
0078-0415Zortresseverolimus
0078-0417Zortresseverolimus
0078-0422Zortresseverolimus

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.